HR 1418 · 118th Congress 2023–2025, ended

Animal Drug and Animal Generic Drug User Fee Amendments of 2023

Latest action · Sep 20, 2023 Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 210.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 7, 2023
  2. Passed HouseJul 17, 2023
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Animal Drug and Animal Generic Drug User Fee Amendments of 2023

This bill reauthorizes the Food and Drug Administration (FDA) to collect fees for brand-name and generic animal drug applications through FY2028. It also makes related updates to fee calculations and FDA reporting requirements.

The bill also (1) provides for a specific fee for requests to establish generic investigational new animal drug files and requires other application fees to be adjusted accordingly; (2) authorizes the FDA to remove species from the definition of major species (currently horses, dogs, cats, cattle, pigs, chickens, and turkeys); and (3) provides statutory authority for the FDA to report on its progress supporting antimicrobial stewardship in veterinary settings (i.e., supporting responsible use of antimicrobial drugs for animals to slow the development of drug-resistant bacteria).

Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the FDA before they may be offered on the commercial market. The FDA is authorized to collect fees for animal drug applications in order to support its regulatory activities; this authority currently expires at the end of FY2023.

Cosponsors 2

Members who signed on, in the order they did. Signatures ran from Mar 7, 2023 to Jun 6, 2023; 1 is an original cosponsor, there from the day it was introduced.

SeatCosponsorSigned on
D-WAKim SchrierOriginalMar 7, 2023
D-NVSusie LeeJun 6, 2023

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Mar 7, 2023Markup May 24, 2023Reported Jun 9, 2023
Health Subcommittee
Referred Mar 17, 2023Markup May 17, 2023Reported May 17, 2023

Actions 16

Everything that happened, newest first.

  1. Sep 20, 2023Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 210.
  2. Jul 18, 2023Received in the Senate.
  3. Jul 17, 2023Mr. Bilirakis moved to suspend the rules and pass the bill, as amended.
  4. Jul 17, 2023Considered under suspension of the rules. (consideration: CR H3620-3624)
  5. Jul 17, 2023DEBATE - The House proceeded with forty minutes of debate on H.R. 1418.
  6. Jul 17, 2023Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H3620-3623)
  7. Jul 17, 2023Motion to reconsider laid on the table Agreed to without objection.
  8. Jun 9, 2023Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-104.
  9. Jun 9, 2023Placed on the Union Calendar, Calendar No. 80.
  10. May 24, 2023Committee Consideration and Mark-up Session Held.
  11. May 24, 2023Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
  12. May 17, 2023Subcommittee Consideration and Mark-up Session Held.
  13. May 17, 2023Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by the Yeas and Nays: 29 - 0 .
  14. Mar 17, 2023Referred to the Subcommittee on Health.
  15. Mar 7, 2023Introduced in House
  16. Mar 7, 2023Referred to the House Committee on Energy and Commerce.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H3620–H3624Text printed H3620–H3623Greg Pence R-IN, Gus M. Bilirakis R-FL, Kim Schrier D-WA, Sheila Jackson Lee D-TXJul 17, 2023

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Committee report

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article 1 Section 8 Clause 3 of the U.S. Constitution The single subject of this legislation is: To amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs and generic new animal drugs.

The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 43, March 7, 2023, page H1152.

Related bills 2

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 1844Animal Drug and Animal Generic Drug User Fee Amendments of 2023Related billJul 26, 2023
HR 5860Continuing Appropriations Act, 2024 and Other Extensions ActRelated billSep 30, 2023

Titles 13

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend the Federal Food, Drug, and Cosmetic Act to reauthorize user fee programs relating to new animal drugs and generic new animal drugs.
Short Title(s) as Introduced
Animal Drug User Fee Amendments of 2023
Short Title(s) as Reported to House
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Short Title(s) as Passed House
Animal Drug and Animal Generic Drug User Fee Amendments of 2023
Short Title(s) as Introduced for portions of this bill
Animal Drug User Fee Amendments of 2023
Animal Generic Drug User Fee Amendments of 2023
Short Title(s) as Reported to House for portions of this bill
Animal Generic Drug User Fee Amendments of 2023
Animal Drug User Fee Amendments of 2023
Short Title(s) as Passed House for portions of this bill
Animal Drug User Fee Amendments of 2023
Animal Generic Drug User Fee Amendments of 2023
Short Titles for portions of this bill from PCS (Placed on Senate Calendar) bill text
Animal Drug User Fee Amendments of 2023
Animal Generic Drug User Fee Amendments of 2023
Short Title(s) from PCS (Placed on Senate Calendar) bill text
Animal Drug and Animal Generic Drug User Fee Amendments of 2023

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 4

Each version as it was printed, newest first.

  1. Sep 20, 2023Placed on Calendar Senate
  2. Jul 17, 2023Engrossed in House
  3. Jun 9, 2023Reported in House
  4. Mar 7, 2023Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.